About | Free Trial

Last Update

2015-09-16T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Patrick Reichenberger?

Mr. Patrick Reichenberger MBA

Vice President Commercial Operations

Raptor Pharmaceutical Corp

Direct Phone: (415) ***-****       

Raptor Pharmaceutical Corp

7 Hamilton Landing Suite 100

Novato, California 94949

United States

Company Description

Raptor Pharmaceuticals Corp. (Raptor) is a development-stage biotechnology company. The Company is focused on the development of new drugs. Raptor is developing drug therapies for the treatment of genetic diseases, such as Nephropathic Cystinosis (Cystino ... more

Find other employees at this company (175)

Background Information

Employment History

Director, Commercial Development
XOMA Ltd.

Group Product Manager
Genentech , Inc.

Senior Product Manager
Athena Neurosciences , Inc.

Affiliations

Advisory Board Member
CALBIO2013

Advisory Board Member
BayBio

Director of Marketing
Questcor Pharmaceuticals , Inc.

Education

B.S.
Biology
University of California , Los Angeles

M.B.A.

Pepperdine University

Web References (38 Total References)


Valerie was invited to join Patrick ...

www.cystinosis.com [cached]

Valerie was invited to join Patrick Reichenberger, Vice President, Commercial Operations for Raptor Pharmaceutical Corp., and Henk Doude van Troostwijk, Manager of Raptor's European operations at their table.


Raptor Pharmaceutical Corp. - Definitive Proxy Statement

ir.raptorpharma.com [cached]

Effective September 1, 2011, Ms. Tsuchimoto and Mr. Reichenberger both received 3% increases to their fiscal year 2011 base salaries, Mr. Daley received a 5.8% increase and Dr. Rioux received a 7.6% increase to equate their salaries to the 45th percentile for the comparative companies in the Radford survey grouping for companies with under 50 employees.  These raises were to match merit increases among companies in the Radford survey and to maintain the relative position in the Radford survey grouping for companies with under 50 employees.

...
Patrick Reichenberger VP, Commercial Operations
...
Fiscal Year 2012 Goal Achievements for Patrick Reichenberger, Our Vice President, Commercial Operations  Mr. Reichenberger had a minor role in the achievement of our corporate program goals but achieved significant individual goals. Corporate program goals account for 15% of Mr. Reichenberger's fiscal year 2012 annual incentive bonus, while individual goals account for 85%.  Mr. Reichenberger's annual incentive bonus (which target was up to 27.5% of his base salary) for fiscal year 2012 totaled $50,000 and was based upon achieving 100% of his corporate program goal of establishing a European headquarters and hiring a European General Manager of European commercial operations and on achieving 100% of the following individual goals (representing an achievement score percentage of 85%):  setting up a patient registry by August 2012; establishing a reimbursement HUB for RP103 (RaptorCares™) by August 2012; commencing implementation of early-access, named patient program for cystinosis patients; continuing development of strategic financial model by major product programs in accordance with project plan; completing a European distribution agreement.
...
Patrick Reichenberger, VP, Commercial Operations
...
 On September 22, 2011, after a discussion of the equity compensation situation and alternatives, our board approved the recommendation of our Compensation Committee.  With respect to our Named Executive Officers and our non-employee directors, our board awarded stock options relating to fiscal year 2012 to purchase up to the following number of shares at an exercise price of $5.13 per share, vesting 6/48ths on the 6 month anniversary of the grant date and 1/48th per month thereafter, with a 10 year expiry from grant date: Dr. Starr 345,048 shares; Ms. Tsuchimoto, Mr. Daley and Dr. Rioux 113,616 shares each; and Mr. Reichenberger 90,000 shares.
...
In addition, our Named Executive Officers were awarded annual stock option grants to purchase up to the following number of shares: Dr. Starr 115,016 shares; Ms. Tsuchimoto, Mr. Daley and Dr. Rioux 37,872 shares each; and Mr. Reichenberger 20,000 shares.  Dr.
...
Patrick Reichenberger, VP, Commercial Operations


Valerie was invited to join Patrick ...

www.cystinosisfoundation.org [cached]

Valerie was invited to join Patrick Reichenberger, Vice President, Commercial Operations for Raptor Pharmaceutical Corp., and Henk Doude van Troostwijk, Manager of Raptor's European operations at their table.


Patrick ...

www.calbio2013.com [cached]

Patrick Reichenberger

...
Patrick Reichenberger
Vice President, Commercial Operations, Raptor Pharmaceuticals
...
Patrick Reichenberger Patrick has over 20 years of experience in biotech/pharma sales and marketing including orphan product development and commercialization. He is responsible for global marketing and sales at Raptor Pharmaceuticals. Prior to joining Raptor, he served as Senior Director at XOMA LLC where he led XOMA's commercial development department. Patrick also managed marketing, sales, reimbursement and distribution at Questcor Pharmaceuticals supporting the re-launch of H.P. Acthar® Gel for the treatment of infantile spasm, an ultra-orphan, pediatric disease. Prior to Questcor, he held positions of increasing responsibility at Genentech, Athena Neurosciences, a division of Elan, and Parke-Davis Pharmaceuticals. Patrick has an M.B.A. from Pepperdine University, where he graduated with Honors, and a B.S. in Biology from University of California, Los Angeles.


Management Team | Raptor Pharmaceutical Corp.

www.raptorpharma.com [cached]

Patrick Reichenberger

...
Patrick Reichenberger Vice President, Commercial Operations
Patrick Reichenberger joined Raptor as the Vice President, Commercial Operations. He has over 20 years of experience in biotech/pharma sales and marketing including orphan product development and commercialization. Prior to joining Raptor, Mr. Reichenberger served as Senior Director at XOMA LLC. In this role he led XOMA's commercial development department with particular emphasis on XOMA 052, an anti-IL-1 antibody for cardiovascular disease and Behcet's Uveitis, an orphan disease. Prior to XOMA, Mr. Reichenberger managed marketing, sales, reimbursement and distribution at Questcor Pharmaceuticals supporting the re-launch of H.P. Acthar® Gel for the treatment of infantile spasm, an ultra-orphan, pediatric disease. Prior to Questcor, he held positions of increasing responsibility at Genentech, Athena Neurosciences, a division of Elan, and Parke-Davis Pharmaceuticals. Patrick has an M.B.A. from Pepperdine University, where he graduated with Honors, and a B.S. in Biology from University of California, Los Angeles.

Similar Profiles

Other People with this Name

Other people with the name Reichenberger

Ann Reichenberger
4Imprint

Marc Reichenberger
AT&T Center

Antje Reichenberger
SYSTEMS INTERACTIVE

Bob Reichenberger
Ciena Corporation

Joseph Reichenberger
Loyola Marymount University

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory